| Active ingredient (INN) | Atazanavir |
|---|---|
| Brand names | Reyataz, Atazanavir Krka, Atazanavir Teva, Atazanavir Stada, REYATAZ atazanavir |
| ATC level 5 | J05AE08 |
| ATC level 4 | J05AE |
| Therapeutic category | Auto-created by EMA — Withdrawn / Refused / Revoked Medicines scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Alphapharm Pty Ltd, Cipla Australia Pty Ltd, TEVA PHARMACEUTICALS USA, INC., Bristol-Myers Squibb Australia Pty Ltd |
| Registrations on file | 18 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Apotex | 200 mg | — | 🇦🇺 AU | — | Active |
| Apo | 150 mg | — | 🇦🇺 AU | — | Active |
| Alphapharm | 150 mg | — | 🇦🇺 AU | Alphapharm Pty Ltd | Active |
| Alphapharm | 200 mg | — | 🇦🇺 AU | Alphapharm Pty Ltd | Active |
| Apotex | 150 mg | — | 🇦🇺 AU | — | Active |
| Apo | 300 mg | — | 🇦🇺 AU | — | Active |
| Cipla | 300 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Atazanavir Sulfate | 150mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Atazanavir Sulfate | 200mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Atazanavir Sulfate | 300mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| REYATAZ atazanavir | 200mg | — | 🇦🇺 AU | Bristol-Myers Squibb Australia Pty Ltd | Active |
| REYATAZ atazanavir | 300mg | — | 🇦🇺 AU | Bristol-Myers Squibb Australia Pty Ltd | Active |
| EVOTAZ atazanavir/cobicistat | 300 mg | — | 🇦🇺 AU | Bristol-Myers Squibb Australia Pty Ltd | Active |
| ZANAVIR CA atazanavir | 300 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Cipla | 150 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |